Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Nesher Pharmaceuticals (USA) LLC
FDA Inspection
•Nesher Pharmaceuticals (USA) LLC•February 2, 2009

Nesher Pharmaceuticals (USA) LLC – FDA Inspection, Feb 2, 2009

Record Details

This FDA Inspection record concerns Nesher Pharmaceuticals (USA) LLC, with an inspection on February 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Nesher Pharmaceuticals (USA) LLC
Inspection Date
February 2, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 70e5d26e-3928-4505-b1d1-7fa3f8b50ec1

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
554855
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

35
  1. 21 CFR 211.105(a)Identification of containers, lines, equipment
  2. 21 CFR 314.81(b)(2)(iv)(b)Mfg and control changes not requiring a supplemental app.
  3. 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
  4. 21 CFR 211.188(b)(11)Identification of persons involved, each significant step
  5. 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
  6. 21 CFR 211.194(b)Test method modification records not maintained
  7. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  8. 21 CFR 211.192Quality control unit review of records
  9. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  10. 21 CFR 211.160(a)Following/documenting laboratory controls

Showing 10 of 35 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Nesher Pharmaceuticals (USA) LLC

7
DateClassificationOfficeProject area
August 12, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 31, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 3, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 7, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 7, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Nesher Pharmaceuticals (USA) LLC
  • FDA Inspection 1151305 - 2021-08-12
  • FDA Inspection 1095659 - 2019-05-31
  • FDA Inspection 1002432 - 2017-02-03
  • FDA Inspection 925349 - 2015-05-07
  • FDA Inspection 855762 - 2013-11-07

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nesher Pharmaceuticals (USA) LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.